Does ADALIMUMAB Cause Blindness transient? 200 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Blindness transient have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
200
Reports of Blindness transient with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
0
Deaths
35
Hospitalizations
How Dangerous Is Blindness transient From ADALIMUMAB?
Of the 200 reports, 35 (17.5%) required hospitalization, and 3 (1.5%) were considered life-threatening.
Is Blindness transient Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 200 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Blindness transient?
AFLIBERCEPT (987)
METFORMIN (153)
DIMETHYL (119)
INTERFERON BETA-1A (102)
NATALIZUMAB (101)
RANIBIZUMAB (100)
BROLUCIZUMAB-DBLL (99)
FINGOLIMOD (89)
BEVACIZUMAB (72)
DUPILUMAB (59)
Which ADALIMUMAB Alternatives Have Lower Blindness transient Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB